LADENBURG THALMANN FINANCIAL SERVICES INC. - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 11 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$6,000
+200.0%
500
+25.0%
0.00%
Q4 2016$2,0000.0%4000.0%0.00%
Q3 2016$2,000
-50.0%
400
-46.1%
0.00%
Q2 2016$4,0000.0%7420.0%0.00%
Q1 2016$4,0000.0%742
+85.5%
0.00%
Q4 2015$4,000
-55.6%
400
-24.7%
0.00%
Q3 2015$9,000
-10.0%
531
+6.2%
0.00%
Q2 2015$10,000
+42.9%
500
+25.0%
0.00%
Q1 2015$7,000
+16.7%
4000.0%0.00%
Q4 2014$6,0004000.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Venator Capital Management Ltd. 218,300$4,248,0003.89%
Consonance Capital Management LP 1,176,195$22,889,0002.30%
RATIONAL ADVISORS LLC 64,000$1,245,0000.40%
PRINCETON CAPITAL MANAGEMENT INC 34,825$678,0000.36%
TURNER INVESTMENTS LLC 91,500$1,780,0000.33%
FALCON POINT CAPITAL, LLC 26,596$518,0000.18%
Freedom Investment Management, Inc. 76,469$1,488,0000.15%
Baker Brothers Advisors 499,193$9,714,0000.08%
Spark Investment Management LLC 27,600$536,0000.08%
OXFORD ASSET MANAGEMENT LLP 128,247$2,496,0000.07%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders